Intention to test for prostate cancer

The aim of this study was to assess intention among men to take a prostate-specific antigen (PSA) test, when this test was: (i) offered by a doctor or (ii) based on the men’s own initiative. A further aim was to use the Theory of Planned Behaviour (TPB) to predict the most important determinants for...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 41; no. 7; pp. 990 - 997
Main Authors Berglund, Gunilla, Nilsson, Sten, Nordin, Karin
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.05.2005
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aim of this study was to assess intention among men to take a prostate-specific antigen (PSA) test, when this test was: (i) offered by a doctor or (ii) based on the men’s own initiative. A further aim was to use the Theory of Planned Behaviour (TPB) to predict the most important determinants for taking a PSA test. In addition, the intention to take a PSA test among men who had the opportunity to read a PSA leaflet published by the Swedish Cancer Society was compared with men who had not read the leaflet. A total of 1000 men, age range 40–70 years, were selected randomly from a population database. The TPB model was used to measure attitudes about PSA testing. The constructed questionnaire was posted to the selected sample. Half of the sample received only the TPB questionnaire and the other half also received a PSA leaflet. The response rate was approximately 63%. The results showed that men would be less likely to request a PSA test if their doctor did not suggest the test (mean ≈ 3.8 (range 1–7 from not likely to very likely)). However, if they were offered the test, most would take it (mean ≈ 6.0 (range 1–7)). The positive ‘Attitude factor’ towards the test was the most salient predictor of both behaviours. In addition, the probability of requesting a test was higher among those who had already taken a PSA test. The men who did not receive the PSA leaflet reported a higher intention to take the test than those who had received it. Overall, 47% of the variance was explained concerning men’s intention to take a PSA test when offered by a doctor and 25% of men’s intention to request the PSA test themselves. In conclusion, the majority of men in this study had a positive attitude towards PSA testing. The results indicate that most men could be expected to accept screening. The intention to take the PSA test was lower among the men who had received the PSA leaflet.
AbstractList The aim of this study was to assess intention among men to take a prostate-specific antigen (PSA) test, when this test was: (i) offered by a doctor or (ii) based on the men's own initiative. A further aim was to use the Theory of Planned Behaviour (TPB) to predict the most important determinants for taking a PSA test. In addition, the intention to take a PSA test among men who had the opportunity to read a PSA leaflet published by the Swedish Cancer Society was compared with men who had not read the leaflet. A total of 1000 men, age range 40-70 years, were selected randomly from a population database. The TPB model was used to measure attitudes about PSA testing. The constructed questionnaire was posted to the selected sample. Half of the sample received only the TPB questionnaire and the other half also received a PSA leaflet. The response rate was approximately 63%. The results showed that men would be less likely to request a PSA test if their doctor did not suggest the test (mean approximately 3.8 (range 1-7 from not likely to very likely)). However, if they were offered the test, most would take it (mean approximately 6.0 (range 1-7)). The positive "Attitude factor" towards the test was the most salient predictor of both behaviours. In addition, the probability of requesting a test was higher among those who had already taken a PSA test. The men who did not receive the PSA leaflet reported a higher intention to take the test than those who had received it. Overall, 47% of the variance was explained concerning men's intention to take a PSA test when offered by a doctor and 25% of men's intention to request the PSA test themselves. In conclusion, the majority of men in this study had a positive attitude towards PSA testing. The results indicate that most men could be expected to accept screening. The intention to take the PSA test was lower among the men who had received the PSA leaflet.
The aim of this study was to assess intention among men to take a prostate-specific antigen (PSA) test, when this test was: (i) offered by a doctor or (ii) based on the men’s own initiative. A further aim was to use the Theory of Planned Behaviour (TPB) to predict the most important determinants for taking a PSA test. In addition, the intention to take a PSA test among men who had the opportunity to read a PSA leaflet published by the Swedish Cancer Society was compared with men who had not read the leaflet. A total of 1000 men, age range 40–70 years, were selected randomly from a population database. The TPB model was used to measure attitudes about PSA testing. The constructed questionnaire was posted to the selected sample. Half of the sample received only the TPB questionnaire and the other half also received a PSA leaflet. The response rate was approximately 63%. The results showed that men would be less likely to request a PSA test if their doctor did not suggest the test (mean ≈ 3.8 (range 1–7 from not likely to very likely)). However, if they were offered the test, most would take it (mean ≈ 6.0 (range 1–7)). The positive ‘Attitude factor’ towards the test was the most salient predictor of both behaviours. In addition, the probability of requesting a test was higher among those who had already taken a PSA test. The men who did not receive the PSA leaflet reported a higher intention to take the test than those who had received it. Overall, 47% of the variance was explained concerning men’s intention to take a PSA test when offered by a doctor and 25% of men’s intention to request the PSA test themselves. In conclusion, the majority of men in this study had a positive attitude towards PSA testing. The results indicate that most men could be expected to accept screening. The intention to take the PSA test was lower among the men who had received the PSA leaflet.
Author Nordin, Karin
Nilsson, Sten
Berglund, Gunilla
Author_xml – sequence: 1
  givenname: Gunilla
  surname: Berglund
  fullname: Berglund, Gunilla
  email: gunilla.berglund@pubcare.uu.se
  organization: Department of Public Health and Caring Sciences, Uppsala University, Uppsala Science Park, SE-751 83 Uppsala, Sweden
– sequence: 2
  givenname: Sten
  surname: Nilsson
  fullname: Nilsson, Sten
  organization: Department of Oncology, Radiumhemmet, Karolinska Sjukhuset, SE-171 76 Stockholm, Sweden
– sequence: 3
  givenname: Karin
  surname: Nordin
  fullname: Nordin, Karin
  organization: Department of Public Health and Caring Sciences, Uppsala University, Uppsala Science Park, SE-751 83 Uppsala, Sweden
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16763221$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15862747$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-72296$$DView record from Swedish Publication Index
http://kipublications.ki.se/Default.aspx?queryparsed=id:1930891$$DView record from Swedish Publication Index
BookMark eNp9kU9v1DAQxS1URLeFL8AB5VIuVZax4_iPxKUqFCpV4gJcLceeIC-78WI7IL49jjaiJ5DGsmX95nn83gU5m-KEhLyksKVAxZvdFnfObhlAvwVaiz4hG6qkbkH17IxsQPe6VcD1ObnIeQcAUnF4Rs5prwSTXG7I1f1UcCohTk2JTcFcmjGm5phiLrZg4-zkMD0nT0e7z_hi3S_Jl7v3n28_tg-fPtzf3jy0jgtVWoSBOehQeD1ybi3jshdgu_qUU-B61gvBhPPUczEMndIDFR4GB1biOHjVXRJ50s2_8DgP5pjCwabfJtpQz9Gb9f57WJbJaKjuQGlaO6__2fkufL0xMX0z82wkY1pU-vWJrqI_5vppcwjZ4X5vJ4xzNkIqyrhaBmIn0FVDcsLxrzAFs4RgdmYJwSwhGKC1lllererzcED_2LK6XoGrFbDZ2f2YqskhP3JCio6xRejticPq-c-AyWQXsAbiQ0JXjI_hf3P8AaQPppg
CitedBy_id crossref_primary_10_1016_j_puhe_2008_06_011
crossref_primary_10_1016_j_jalz_2007_09_005
crossref_primary_10_1016_j_pec_2006_05_005
crossref_primary_10_3961_jpmph_2007_40_3_205
crossref_primary_10_4102_phcfm_v15i1_3688
crossref_primary_10_1016_j_eururo_2011_12_059
crossref_primary_10_1177_1557988316637879
crossref_primary_10_1186_1472_6947_10_12
crossref_primary_10_1111_hex_12517
crossref_primary_10_1093_pubmed_fdl008
crossref_primary_10_1007_s11839_015_0522_6
crossref_primary_10_12799_jkachn_2019_30_4_471
crossref_primary_10_1007_s12160_013_9508_4
crossref_primary_10_1007_s40615_016_0305_1
crossref_primary_10_1080_13548500701842933
crossref_primary_10_3109_0284186X_2012_762998
crossref_primary_10_1186_1471_2458_9_431
crossref_primary_10_1158_1055_9965_EPI_08_0027
crossref_primary_10_1007_s10552_010_9687_2
crossref_primary_10_4103_apjon_apjon_34_17
crossref_primary_10_1097_00002093_200607000_00010
crossref_primary_10_1016_j_pec_2008_08_013
crossref_primary_10_1891_1541_6577_29_3_200
crossref_primary_10_7314_APJCP_2014_15_19_8461
Cites_doi 10.1016/0022-1031(86)90045-4
10.5694/j.1326-5377.1999.tb123594.x
10.1080/003655999750017374
10.1016/S0022-5347(01)63766-2
10.1093/gerona/53A.3.M195
10.1001/archfami.8.4.333
10.1046/j.1464-410x.2000.00481.x
ContentType Journal Article
Copyright 2005 Elsevier Ltd
2005 INIST-CNRS
Copyright_xml – notice: 2005 Elsevier Ltd
– notice: 2005 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ADTPV
AOWAS
DF2
DOI 10.1016/j.ejca.2005.01.011
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Uppsala universitet
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-0852
EndPage 997
ExternalDocumentID oai_prod_swepub_kib_ki_se_1930891
oai_DiVA_org_uu_72296
10_1016_j_ejca_2005_01_011
15862747
16763221
S0959804905001036
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29G
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAWTL
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABOCM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACPRK
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
LCYCR
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UV1
WUQ
X7M
XPP
Z5R
ZA5
ZGI
ZXP
~G-
08R
AAUGY
ABPIF
ABPTK
AKALU
IQODW
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAXKI
AAYXX
CITATION
7X8
ADTPV
AOWAS
DF2
AFJKZ
ID FETCH-LOGICAL-c468t-e0b2c03e6d9f44aa247560a3274c80c5256626cd1d46bb389b16d0bc0a7efbd83
IEDL.DBID .~1
ISSN 0959-8049
IngestDate Wed Sep 25 08:58:18 EDT 2024
Sat Aug 24 00:36:24 EDT 2024
Sat Aug 17 00:01:26 EDT 2024
Thu Sep 12 18:44:07 EDT 2024
Thu May 23 23:11:40 EDT 2024
Sun Oct 22 16:08:32 EDT 2023
Fri Feb 23 02:30:40 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Theory of Planned Behaviour
Informative leaflet
Intention
PSA test
Prostate cancer
Urinary system disease
Prostate disease
Theory
Tumoral marker
Pharmacology
Malignant tumor
Prostate specific antigen
Cancerology
Male genital diseases
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c468t-e0b2c03e6d9f44aa247560a3274c80c5256626cd1d46bb389b16d0bc0a7efbd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15862747
PQID 67812488
PQPubID 23479
PageCount 8
ParticipantIDs swepub_primary_oai_prod_swepub_kib_ki_se_1930891
swepub_primary_oai_DiVA_org_uu_72296
proquest_miscellaneous_67812488
crossref_primary_10_1016_j_ejca_2005_01_011
pubmed_primary_15862747
pascalfrancis_primary_16763221
elsevier_sciencedirect_doi_10_1016_j_ejca_2005_01_011
PublicationCentury 2000
PublicationDate 2005-05-01
PublicationDateYYYYMMDD 2005-05-01
PublicationDate_xml – month: 05
  year: 2005
  text: 2005-05-01
  day: 01
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle European journal of cancer (1990)
PublicationTitleAlternate Eur J Cancer
PublicationYear 2005
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Stockholm, National Board of Health and Welfare, 1999
Ajzen, Madden (bib15) 1986; 22
Volk, Cass, Spann (bib4) 1999; 8
Spapen, Damhuis, Kirkels (bib11) 2000; 85
Wolf, Schorling (bib5) 1998; 53
Lodding, Aus, Bergdahl (bib10) 1998; 159
Ajzen, Fishbein (bib12) 1977; 24
Kazdin (bib16) 1980
Diefenbach, Ganz, Pawlow (bib6) 1996; 11
Slevin, Donnelly, Clarksson (bib7) 1999; 171
Ajzen (bib13) 1988
O’Dell, Volk, Cass (bib3) 1999; 48
Uppsala, National Board of Health and Welfare, 2001
Howell (bib14) 1992
Wallskär (bib2) 2000
Sandblom, Mattsson, Nilsson (bib9) 1999; 33
10.1016/j.ejca.2005.01.011_bib8
Sandblom (10.1016/j.ejca.2005.01.011_bib9) 1999; 33
Ajzen (10.1016/j.ejca.2005.01.011_bib12) 1977; 24
Wolf (10.1016/j.ejca.2005.01.011_bib5) 1998; 53
Lodding (10.1016/j.ejca.2005.01.011_bib10) 1998; 159
Kazdin (10.1016/j.ejca.2005.01.011_bib16) 1980
10.1016/j.ejca.2005.01.011_bib1
Slevin (10.1016/j.ejca.2005.01.011_bib7) 1999; 171
Ajzen (10.1016/j.ejca.2005.01.011_bib15) 1986; 22
Wallskär (10.1016/j.ejca.2005.01.011_bib2) 2000
O’Dell (10.1016/j.ejca.2005.01.011_bib3) 1999; 48
Diefenbach (10.1016/j.ejca.2005.01.011_bib6) 1996; 11
Ajzen (10.1016/j.ejca.2005.01.011_bib13) 1988
Spapen (10.1016/j.ejca.2005.01.011_bib11) 2000; 85
Howell (10.1016/j.ejca.2005.01.011_bib14) 1992
Volk (10.1016/j.ejca.2005.01.011_bib4) 1999; 8
References_xml – year: 2000
  ident: bib2
  article-title: Cancerfonden: OM PSA-TEST
  contributor:
    fullname: Wallskär
– volume: 24
  start-page: 207
  year: 1977
  end-page: 224
  ident: bib12
  article-title: Attitude-behaviour relations: a theoretical analysis and review of empirical research
  publication-title: Psychol Bull
  contributor:
    fullname: Fishbein
– volume: 53
  start-page: 195
  year: 1998
  end-page: 200
  ident: bib5
  article-title: Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent
  publication-title: J Gerontol-Series A, Biol Sci Med Sci
  contributor:
    fullname: Schorling
– year: 1988
  ident: bib13
  article-title: Attitude, personality and behaviour
  contributor:
    fullname: Ajzen
– year: 1980
  ident: bib16
  article-title: Research design in clinical psychology
  contributor:
    fullname: Kazdin
– volume: 171
  start-page: 185
  year: 1999
  end-page: 188
  ident: bib7
  article-title: Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men
  publication-title: Med J Australia
  contributor:
    fullname: Clarksson
– volume: 159
  start-page: 899
  year: 1998
  end-page: 903
  ident: bib10
  article-title: Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen
  publication-title: J Urol
  contributor:
    fullname: Bergdahl
– volume: 11
  start-page: 39
  year: 1996
  end-page: 44
  ident: bib6
  article-title: Screening by the prostate-specific antigen test: what do the patients know
  publication-title: J Cancer Educ
  contributor:
    fullname: Pawlow
– volume: 85
  start-page: 474
  year: 2000
  end-page: 480
  ident: bib11
  article-title: Trends in the curative treatment of localized prostate cancer after the introduction of prostate-specific antigen: data from the Rotterdam Cancer Registry
  publication-title: BJU Int
  contributor:
    fullname: Kirkels
– volume: 8
  start-page: 333
  year: 1999
  end-page: 340
  ident: bib4
  article-title: A randomized controlled trial of shared decision making for prostate cancer screening
  publication-title: Arch Fam Med
  contributor:
    fullname: Spann
– year: 1992
  ident: bib14
  article-title: Statistical methods for psychology
  contributor:
    fullname: Howell
– volume: 22
  start-page: 453
  year: 1986
  end-page: 474
  ident: bib15
  article-title: Prediction and goal-directed behavior: attitudes, intentions and perceived behavioral control
  publication-title: J Exp Soc Psychol
  contributor:
    fullname: Madden
– volume: 48
  start-page: 682
  year: 1999
  end-page: 688
  ident: bib3
  article-title: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions
  publication-title: J Family Pract
  contributor:
    fullname: Cass
– volume: 33
  start-page: 306
  year: 1999
  end-page: 311
  ident: bib9
  article-title: Prostate cancer registration in four Swedish regions 1996
  publication-title: Scan J Urol Nephrol
  contributor:
    fullname: Nilsson
– year: 1988
  ident: 10.1016/j.ejca.2005.01.011_bib13
  contributor:
    fullname: Ajzen
– volume: 22
  start-page: 453
  year: 1986
  ident: 10.1016/j.ejca.2005.01.011_bib15
  article-title: Prediction and goal-directed behavior: attitudes, intentions and perceived behavioral control
  publication-title: J Exp Soc Psychol
  doi: 10.1016/0022-1031(86)90045-4
  contributor:
    fullname: Ajzen
– volume: 171
  start-page: 185
  issue: 4
  year: 1999
  ident: 10.1016/j.ejca.2005.01.011_bib7
  article-title: Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men
  publication-title: Med J Australia
  doi: 10.5694/j.1326-5377.1999.tb123594.x
  contributor:
    fullname: Slevin
– volume: 33
  start-page: 306
  year: 1999
  ident: 10.1016/j.ejca.2005.01.011_bib9
  article-title: Prostate cancer registration in four Swedish regions 1996
  publication-title: Scan J Urol Nephrol
  doi: 10.1080/003655999750017374
  contributor:
    fullname: Sandblom
– ident: 10.1016/j.ejca.2005.01.011_bib1
– year: 2000
  ident: 10.1016/j.ejca.2005.01.011_bib2
  contributor:
    fullname: Wallskär
– volume: 48
  start-page: 682
  issue: 9
  year: 1999
  ident: 10.1016/j.ejca.2005.01.011_bib3
  article-title: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions
  publication-title: J Family Pract
  contributor:
    fullname: O’Dell
– volume: 159
  start-page: 899
  issue: 3
  year: 1998
  ident: 10.1016/j.ejca.2005.01.011_bib10
  article-title: Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen
  publication-title: J Urol
  doi: 10.1016/S0022-5347(01)63766-2
  contributor:
    fullname: Lodding
– year: 1992
  ident: 10.1016/j.ejca.2005.01.011_bib14
  contributor:
    fullname: Howell
– volume: 24
  start-page: 207
  year: 1977
  ident: 10.1016/j.ejca.2005.01.011_bib12
  article-title: Attitude-behaviour relations: a theoretical analysis and review of empirical research
  publication-title: Psychol Bull
  contributor:
    fullname: Ajzen
– volume: 11
  start-page: 39
  issue: 1
  year: 1996
  ident: 10.1016/j.ejca.2005.01.011_bib6
  article-title: Screening by the prostate-specific antigen test: what do the patients know
  publication-title: J Cancer Educ
  contributor:
    fullname: Diefenbach
– volume: 53
  start-page: 195
  issue: 3
  year: 1998
  ident: 10.1016/j.ejca.2005.01.011_bib5
  article-title: Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent
  publication-title: J Gerontol-Series A, Biol Sci Med Sci
  doi: 10.1093/gerona/53A.3.M195
  contributor:
    fullname: Wolf
– ident: 10.1016/j.ejca.2005.01.011_bib8
– volume: 8
  start-page: 333
  issue: 4
  year: 1999
  ident: 10.1016/j.ejca.2005.01.011_bib4
  article-title: A randomized controlled trial of shared decision making for prostate cancer screening
  publication-title: Arch Fam Med
  doi: 10.1001/archfami.8.4.333
  contributor:
    fullname: Volk
– volume: 85
  start-page: 474
  issue: 4
  year: 2000
  ident: 10.1016/j.ejca.2005.01.011_bib11
  article-title: Trends in the curative treatment of localized prostate cancer after the introduction of prostate-specific antigen: data from the Rotterdam Cancer Registry
  publication-title: BJU Int
  doi: 10.1046/j.1464-410x.2000.00481.x
  contributor:
    fullname: Spapen
– year: 1980
  ident: 10.1016/j.ejca.2005.01.011_bib16
  contributor:
    fullname: Kazdin
SSID ssj0007840
Score 1.955998
Snippet The aim of this study was to assess intention among men to take a prostate-specific antigen (PSA) test, when this test was: (i) offered by a doctor or (ii)...
SourceID swepub
proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 990
SubjectTerms Adult
Aged
Attitude to Health
Biological and medical sciences
Humans
Informative leaflet
Intention
Male
Medical sciences
Medicin och hälsovetenskap
Middle Aged
Patient Acceptance of Health Care - psychology
Patient Education as Topic
Pharmacology. Drug treatments
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - psychology
PSA test
Surveys and Questionnaires
Theory of Planned Behaviour
Tumors
Title Intention to test for prostate cancer
URI https://dx.doi.org/10.1016/j.ejca.2005.01.011
https://www.ncbi.nlm.nih.gov/pubmed/15862747
https://search.proquest.com/docview/67812488
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-72296
http://kipublications.ki.se/Default.aspx?queryparsed=id:1930891
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EQQQR39bH2oOepG7aTdP0uPhgVfTiA28hr8oq7C673au_3UmbuijqQWgvadLHzDTzTTIPgCNa5IpRzSJUHxwNFKuiXCVFhNZQwblBidbOULy9Y71Hev2cPs_BWRML49wq_dxfz-nVbO1b2p6a7VG_3753K1jcbVylVbECl3abojJCmT59n7l5ZLwKiqyXu7C3D5ypfbzsq5Z-XSXGI_5NOS2P5ARJVtS1Ln4Co98yjVba6XIVVjysDLv1m6_BnB2sw-Kt3zjfgOPKVd0xISyHIcLLMkS0Go5czAeizVA75o834fHy4uGsF_kKCZGmjJeRJSrRpGOZyQtKpUxohghGdtDU1JzoFPEMGizaxIYypRCbqJgZojSRmS2U4Z0tmB8MB3YHQq60zGlBiizp0DTHm6AhZdCaUNwYSfIAThrSiFGdCEM0HmKvwhHSVbRMBYnxiANIG-qJL-wUOFP_Oa71hdSzRzEUmyTBDocN7QX-CG53Qw7scDoRqHURq3AewHbNktnYlLsKQ1kARzWPPq-43Nrn_aeuGI5fxHQqsiTJWQDkh25Onwnf_tZ3p5hYgfCX8Dze_efn7sFSlQq2cqDch_lyPLUHCHJK1aqkuAUL3aub3t0HMCn6Tg
link.rule.ids 230,315,786,790,891,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFH8qTAIkhDZgEMZoDnBCWZ3UcZwjgqEOKJdR1Jvlr0wFqa3a9Lq_fc-Js6qo4zApuTh2Pt5z3vs9-30AnNMiV4xqFqH64GigWBXlKikitIYKzg3OaO0Mxf4j6w3o3TAdtuC6iYVxbpVe9tcyvZLWvqXjqdmZjkadn24Fi7uNq7QqVsA24IOD865-w7ffSz-PjFdRkfV6F3b3kTO1k5d90dIvrMR4xP_STrtTOUeaFXWxi3Vo9E2q0Uo93X6EPY8rw6v61T9By473Yavvd84P4KLyVXdcCMtJiPiyDBGuhlMX9IFwM9SO-7NDGNx-f7ruRb5EQqQp42VkiUo06Vpm8oJSKROaIYSRXbQ1NSc6RUCDFos2saFMKQQnKmaGKE1kZgtlePczbI4nY3sMIVda5rQgRZZ0aZrjTdCSMmhOKG6MJHkAlw1pxLTOhCEaF7EX4QjpSlqmgsR4xAGkDfXECj8Fiup3x52tkHr5KIbzJkmwQ7uhvcA_wW1vyLGdLOYC1S6CFc4DOKpZshybcldiKAvgvObR3ysuufbN6PlKTGa_xGIhsiTJWQBkTTen0IRvfx25U8ytQPxLeB6f_OfntmG799R_EA8_Hu-_wE6VF7bypjyFzXK2sF8R8ZTqrJrRfwDsmfvg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intention+to+test+for+prostate+cancer&rft.jtitle=European+journal+of+cancer+%281990%29&rft.au=Berglund%2C+Gunilla&rft.au=Nilsson%2C+Sten&rft.au=Nordin%2C+Karin&rft.date=2005-05-01&rft.pub=Elsevier+Ltd&rft.issn=0959-8049&rft.eissn=1879-0852&rft.volume=41&rft.issue=7&rft.spage=990&rft.epage=997&rft_id=info:doi/10.1016%2Fj.ejca.2005.01.011&rft.externalDocID=S0959804905001036
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-8049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-8049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-8049&client=summon